<<

Br J Ophthalmol: first published as 10.1136/2005.bjjul05atag on 17 June 2005. Downloaded from

Creig Hoyt, Editor RISK OF methotrexate for chronic . This therapy appears to be effective and safe for chronic anterior and in children. ASSOCIATED WITH See p 806 Onchocerciasis is a microfilarial disease THE CONTRALATERAL EYE PRESSURE REDUCTION that causes ocular disease and blind- PHENOMENON ness. The question of whether it is In 1924 Weekers described the effect of intraocular pressure in contralateral eyes associated with glaucoma remains con- being treated for glaucoma and coined the term ‘‘ophthalmotonic consensual tentious. Egbert and co-workers studied reaction.’’ Many studies have reported that when a fall in intraocular pressure occurs a group of patients in and found in one eye the other eye has a fall as well. This has been reported in association with that glaucoma was seen in 10.6% of ocular compression, tonography, trauma, cauterisation of the , paracentesis, those with onchocerciasis and 2.6% of laser trabeculoplasty as well as fistulising surgery. Vysniauskiene and co-workers those with and no onchocer- report their finding in a study of 24 consecutive patients who underwent ciasis evident. This association of glau- trabeculectomy with mitomycin C. In this study the mean intraocular pressure in coma with onchocerciasis adds one the contralateral eye decreased independent of whether these contralateral eyes were more imperative to the move to eradi- undergoing topical ocular hypotensive therapy or not. cate onchocerciasis by continuation of See p 809 control programmes and drug treatment with . See p 796 WHO IS WILLING TO BE A CORNEAL DONOR? Corneal transplantation is a sight saving procedure with a very high success rate. RETINAL DAMAGE Nevertheless, in many parts of the world a shortage of donor tissue is a major obstacle to providing this surgical therapy. Yew and co-workers studied 675 housing ASSOCIATED WITH units in Singapore to assess the knowledge and willingness of Singapore adults for SILICONE OIL corneal donation. In Singapore, awareness of corneal donation is high and a Silicone oil has been used in the significant proportion of participants are willing to donate their but specific management of complicated retinal knowledge should be increased among this adult patient population. detachment surgery. It provides pro- See p 835 longed intraocular tamponade. Un- http://bjo.bmj.com/ explained visual loss is a complication EPIKERATOPLASTY FOR following silicone oil removal that is Epikeratoplasty is a form of lamellar refractive corneal surgery. This surgical infrequently reported. In a study by procedure was first used to correct but has been adapted for treatment of Cazabon and co-workers of three . Nakamura and co-workers studied 12 penetrating keratoplasty specimens patients with unexplained visual loss from patients with keratoconus who had already undergone epikeratoplasty. In nine following the removal of silicone oil of the 12 lenticules keratoconus-like disruptions were found in Bowman’s layer. multifocal electroretinography indi- Peripheral and posterior keratocyte repopulation of the lenticules was observed in all on September 29, 2021 by guest. Protected copyright. cated selective damage to the central cases. The authors suggest that epithelial cells in keratocytes repopulated in the part of the macula especially the outer lenticules retained keratoconus-like biochemical abnormalities such as upregulation and middle layers. The exact mechan- Sp1 and downregulation of a1-P1 and a2M. The authors speculate that both ism for this retinal damage remains keratocytes and corneal epithelium may participate in the development of undefined. keratoconus. See p 799 See p 841 METHOTREXATE IN ‘‘LIGHT’’ V CLASSIC’’ LASER TREATMENT FOR DIABETIC UVEITIS IN CHILDREN MACULAR OEDEMA Juvenile idiopathic arthritis is the most Macular oedema is the most common cause of visual loss in patients with diabetic common cause of uveitis in children. . Its prevalence in the diabetic population has increased fivefold over the Heretofore, corticosteroids have been past 10 years. Laser treatment has been shown to be effective in reducing the risk of the mainstay of treatment but long moderate visual loss in eyes with clinically significant macular oedema. Bandello term adverse effects of corticosteroids and co-workers completed a prospective randomised pilot clinical trial in which 29 are well documented. The increasing eyes of 24 diabetics with mild to moderate non-proliferative and use of methotrexate in the treatment of clinically significant macular oedema were randomised to either classic or light laser patients with juvenile idiopathic arthri- therapy. In this study there was no statistical difference in the outcome between the tis has been associated with a reduction two groups. The authors suggest that ‘‘light’’ photocoagulation for clinically in side effects compared to steroid significant macular oedema may be as effective as classic laser treatment. They therapy. Malik and Pavesio report the suggest that a larger equivalence trial should be completed. results of 10 children treated with See p 864